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ABSTRACT
Optical coherence tomography (OCT) is a commonly
used imaging modality in the evaluation of
glaucomatous damage. The commercially available
spectral domain (SD)-OCT offers benefits in glaucoma
assessment over the earlier generation of time domain-
OCT due to increased axial resolution, faster scanning
speeds and has been reported to have improved
reproducibility but similar diagnostic accuracy. The
capabilities of SD-OCT are rapidly advancing with 3D
imaging, reproducible registration, and advanced
segmentation algorithms of macular and optic nerve
head regions. A review of the evidence to date suggests
that retinal nerve fibre layer remains the dominant
parameter for glaucoma diagnosis and detection of
progression while initial studies of macular and optic
nerve head parameters have shown promising results.
SD-OCT still currently lacks the diagnostic performance
for glaucoma screening.
INTRODUCTION
Glaucoma is a multi-factorial optic neuropathy
characterised by progressive structural loss of
retinal ganglion cells (RGC) that may result in
vision loss and irreversible blindness. The ability to
detect structural loss is fundamental in the diagno-
sis and management of glaucoma. While glau-
comatous structural damage can be assessed
subjectively by clinically examining the optic nerve
head (ONH) and peripapillary retinal nerve fibre
layer (RNFL), the introduction of ocular imaging
modalities into clinical management has allowed
for supplemental objective and quantitative evalu-
ation of ocular structure.
Optical coherence tomography (OCT) is a com-
monly used imaging technology in the evaluation
of glaucomatous structural damage. OCTwas intro-
duced over 20 years ago and is a non-invasive
optical technique that allows for in vivo cross-
sectional imaging of the ONH and retina.1 2 The
recent commercially available iteration of the OCT
technology, spectral domain (SD)-OCT, has theoret-
ical advantages in glaucoma assessment over the
earlier generation of time domain (TD)-OCT due
to increased axial resolution and faster scanning
speed that lead to lower susceptibility to eye move-
ment artefacts. The evidence to date suggests that
SD-OCT offers improved reproducibility; however,
the glaucoma diagnostic accuracy of SD-OCT and
TD-OCT is statistically similar.3 4
SD-OCT is rapidly evolving with faster scanning
speeds, 3D image acquisition patterns, reproducible
registration and advanced segmentation algorithms.
The clinical utility of SD-OCT in glaucoma has pri-
marily focused on the evaluation RNFL parameters
because it enables a comprehensive assessment of
all the RGC axons as they approach the ONH.
However, the variability of the surrounding struc-
tures and the presence of coexisting pathology may
impact reliable measurement. As such, the
enhanced performance of SD-OCT allows for the
assessment of macular parameters for glaucoma
evaluation because the macula has the highest con-
centration of RGC in the retina (approximately
50% of the RGC of the entire retina); thus, loss of
these cells may potentially be more readily detected
in this area. Furthermore, given the ability of
SD-OCT to produce 3D datasets, there is now
potential to assess ONH parameters for glaucoma
evaluation with greater accuracy and improved pro-
gression detection in consecutive testing by precise
image registration. There are currently several com-
mercially available SD-OCT devices with varying
parameters and unique features. As such, the dis-
cussion of parameters and features provided in this
manuscript may not be applicable across every
SD-OCT device. In this manuscript, we review the
recent advances in the use of SD-OCT for glau-
coma diagnosis, screening and detection of
progression.
GLAUCOMA DIAGNOSIS
The use of SD-OCT for glaucoma diagnosis has
become a common clinical practice. Numerous
studies have demonstrated that RNFL and macular
thickness parameters are reproducible, and with
high diagnostic sensitivity and specificity in discrim-
inating between healthy and glaucomatous eyes
(table 1).4 5
The diagnostic capabilities of SD-OCT for dis-
criminating between healthy and glaucomatous eyes
using average RNFL thickness have been reported
to have an area under receiver operating character-
istics curve value of around 0.9.6 However, the dis-
crimination ability is dependent on the severity
stage of glaucoma, with better performance in dis-
criminating between healthy and more advance
disease compared with discrimination of early
stages of glaucoma.7
Acquisition of 3D images of the ONH region
enables accurate and reproducible measurements of
ONH parameters that include: disc and rim area,
cup to disc ratio, cup volume and others. A diag-
nostic capability study with SD-OCT of glaucoma
and age-matched healthy controls reported that
these ONH parameters are able to discriminate
between healthy and glaucomatous eyes similar to
RNFL thickness.8 Another study with glaucoma,
preperimetric glaucoma and healthy subjects
demonstrated that RNFL thickness was better than
any tested ONH parameter.9 The contradictory
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results of these two studies may be attributed to difference in
glaucoma severity within the study samples. However, both
studies reported similar diagnostic capability with rim area and
average RNFL thickness in advanced glaucoma. The role of
SD-OCT ONH analysis in glaucoma diagnosis is yet to be
determined.
While total macular thickness (TMT) has been associated with
glaucoma, the diagnostic capabilities have been reported to be
worse than with RNFL thickness. However, SD-OCT segmenta-
tion algorithms have enabled quantification of individual layers in
the macular region that are particularly impacted by glaucomatous
damage, specifically, macular RNFL (mRNFL), ganglion cell layer
with inner plexiform layer (GCIPL) and ganglion cell complex
(GCC=mRNFL+GCIPL). Recent studies reported similar area
under the receiver operating characteristics diagnostic capability of
GCIPL that was comparable with RNFL10 11 and ONH para-
meters.11 12 Furthermore, of the various GCIPL-specific para-
meters (average, minimum, sectoral), minimum GCIPL has been
reported to be the most sensitive for the diagnosis of
glaucoma.12 13
SD-OCT diagnostic studies have demonstrated that glau-
comatous damage results in thinning of RNFL and GCIPL as
well as ONH structural changes that allow for discrimination
between glaucoma and healthy eyes. However, in most of these
studies, the diagnostic accuracy may not translate when used in
clinical practice for early stage glaucoma detection because the
discrimination studies are usually based on differentiating
healthy eyes from eyes with established glaucomatous visual
field (VF) loss. A recent SD-OCT study compared the diagnostic
ability of RNFL, ONH and macular parameters for diagnosing
preperimetric glaucoma in an observational cohort with
13 years of follow-up.14 The investigators demonstrated that
RNFL parameters performed significantly better than ONH and
macular parameters for detecting preperimetric glaucomatous
damage. It is plausible that a combination of parameters from
the various scanned regions can improve diagnostic perform-
ance; however, this has yet to be evaluated.
Myopia is a risk factor for glaucoma and a confounder that
complicates diagnosis because it presents with structural changes
that can progressively lead to glaucomatous-appearing VF
defects.15 Myopic refractive error and longer axial lengths
impact RNFL and macular thickness measurements due to the
optical projection artefact of the scanning area. It has been
demonstrated that non-glaucomatous myopic eyes tend to have
thinner RNFL and macular parameters that are falsely classified
as abnormal by OCT.16 Recent SD-OCT diagnostic performance
studies on glaucomatous eyes with high myopia have demon-
strated that RNFL and macular thickness parameters have
similar ability to detect glaucoma.17 18
The quality of reporting of diagnostic studies for glaucoma
using OCT has been demonstrated overall to be suboptimal
with only 26.7% of selected papers reporting more than half of
the standards for the reporting of diagnostic accuracy studies
(STARD) criteria items.19 Using the same criteria, 100% of the
Table 1 Summary of selected glaucoma diagnostic accuracy studies
Study, year
(reference) Subjects
Number of
eyes
Baseline MD
(dB) Device
Scan
region Parameter AUC
Mwanza 20118 Glaucoma 73 −10.4 Cirrus SD-OCT ONH
RNFL
Vertical rim thickness
Rim area
RNFL average thickness
0.96
0.96
0.95
Healthy 146 NA
Sung 20129 Glaucoma 229 −6.64 Cirrus SD-OCT ONH
RNFL
Rim area
RNFL average thickness
0.87
0.96Preperimetric
glaucoma
405 −0.66
Healthy 109 −0.45
Kotowski 201210 Glaucoma 63 −2.21 Cirrus SD-OCT Macular
RNFL
GCC average
GCIPL average
RNFL average thickness
0.90
0.90
0.91
Glaucoma suspect 49 −0.32
Healthy 51 −0.18
Mwanza 201211 Glaucoma 58 −3.2 Cirrus SD-OCT Macular
ONH
RNFL
GCIPL minimum
GCIPL average
Vertical cup to disc
ratio
Cup to disc ratio
Rim area
RNFL average thickness
0.96
0.94
0.96
0.93
0.91
0.94
Healthy 99 0.08
Jeoung 201312 Glaucoma
Mild
Moderate/severe
164
142
−2.68
−12.41
Cirrus SD-OCT
Macular
ONH
RNFL
GCIPL minimum
GCIPL average
Rim area
Cup to disc ratio
RNFL average thickness
Mild, moderate/
severe
0.90, 0.96
0.82, 0.91
0.86, 0.94
0.72, 0.86
0.90, 0.96
Healthy 119 −0.22
Takayama 201213 Glaucoma
Early
Advanced
38
20
−2.33
−14.2
Cirrus SD-OCT
Macular
RFNL
GCIPL minimum
GCIPL average
RNFL average thickness
All, early, advanced
0.94, 0.90, 0.99
0.87, 0.82, 0.96
0.92, 0.89, 0.96Healthy 48 −0.07
Lisboa 201314 Preperimetric
glaucoma
48 −0.81 RTVue
SD-OCT
Macular
ONH
RNFL
GCC average
Vertical cup to disc
ratio
Rim area
RNFL average thickness
0.79
0.74
0.72
0.89
Healthy 94 0.02
AUC, area under receiver operating characteristics curve; GCC, ganglion cell complex; GCIPL, ganglion cell inner plexiform layer; MD, mean deviation; ONH, optic nerve head; RNFL,
retinal nerve fibre layer; SD-OCT, spectral domain-optical coherence tomography.
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selected diagnostic studies in this review reported more than
half of the STARD items (mean 71.4%; range 54%–92%).
In summary, the literature to date suggests that RNFL thick-
ness remains the most diagnostically accurate parameter for
detecting glaucoma. Though there have been some conflicting
reports, several studies suggest that the diagnostic performance
of segmented macular and ONH parameters are comparable
with RNFL parameters. Furthermore, there is a reported differ-
ence in RNFL thickness measurement between different
SD-OCT devices attributed to variation in optical properties
and segmentation algorithms, and therefore the measurements
are not inter-changeable between devices.20 However, despite
these variations, the devices have demonstrated similar diagnos-
tic capabilities.21
GLAUCOMA SCREENING
Individuals with glaucoma are usually asymptomatic until late in
the disease processes and it is possible to either slow or prevent
the progression of vision loss if detected early by adequate treat-
ment. Therefore, a glaucoma screening tool for the general
population is desirable. Population-based glaucoma screening is
currently not cost-effective but it may be more beneficial and
cost-effective in a targeted high-risk population such as older
African Americans and Hispanics or those with a family history
of glaucoma. Screening for glaucoma in a community-based
high-risk population with TD-OCT resulted in moderate sensi-
tivity and high specificity for definitive glaucoma suggesting that
the device does not have adequate sensitivity to be used alone
but may have utility in excluding subjects from further evalu-
ation.22 However, SD-OCT has been reported to have higher
sensitivity than TD-OCT in glaucoma screening and may have
potential for early detection in a high-risk population.7 As of
this writing, the use of SD-OCT for glaucoma screening in
high-risk populations has not been reported. The United States
Agency for Healthcare Research and Quality evaluated the evi-
dence from the primary studies that investigated the diagnostic
performance of OCT and reported that all the studies had
appreciable heterogeneity and were at risk of investigating sub-
jects that did not reflect the general or the clinically relevant
population (spectrum bias).6 In summary, OCT currently lacks
the necessary diagnostic performance for general population
glaucoma screening.
GLAUCOMA PROGRESSION
Once glaucoma is diagnosed, a sensitive method for detection of
progression is essential because appropriately intensifying treat-
ment can slow RGC loss and preserve vision. The detection of
glaucoma progression with OCT remains a challenge because
when assessing structural changes over time, it is difficult to dis-
criminate between glaucomatous structural damage and measure-
ment variability or age-related structural loss. A prospective study
assessing age-related loss enrolled 100 healthy subjects for cross-
sectional evaluation and then randomly selected 35 subjects for
30 months of longitudinal evaluation.23 Cross-sectional analysis of
healthy subjects demonstrated a significant negative correlation
between age and average RNFL thickness of −0.33 μm/year while
the longitudinal analysis reported a −0.52 μm/year rate of
age-related loss of RNFL. Furthermore, the same study reported
that age-related structural loss varies as a function of baseline
RNFL where a higher baseline thickness is subject to higher rates
of decline.
Table 2 Summary of selected longitudinal studies of glaucoma progression detection
Study, year
(reference)
Duration
(years) Subjects
Number
of eyes Device
Progression
standard
Progression
parameters Summary
Wollstein
200525
4.7 Glaucoma 55 Prototype
TD-OCT
Visual field RNFL Greater likelihood of progression as measured by
OCT compared with visual fieldGlaucoma
Suspect
9
Wessel 201326 3 Glaucoma 38 Spectralis
SD-OCT
Optic disc photos RNFL Significant difference in rate of structural change
between glaucoma progressors (2.12 μm/year) and
non-progressors (−1.18 μm/year)
Healthy 24
Naghizadeh
201327
2 Glaucoma 51 RTVue
SD-OCT
Visual field RNFL
ONH
macular
Glaucoma eyes had non-significant rates of
structural change in RNFL (−0.33 μm/year), cup area
(0.03 mm2/year), rim area (−0.03 mm2/year) and
GCC (−0.19 μm/year). Only GCC global (3.8%/year)
and focal (1.5%/year) loss volumes had significant
rates of structural change compared with healthy
eyes
Healthy 17
Na 201228 2.1 Glaucoma 141 Cirrus
SD-OCT
Optic disc photos,
red-free RNFL photos
RNFL
macular
No significant difference in sensitivity to detect
glaucoma progression among RNFL (5%), TMT
(14%) and GCIPL (8%)
Healthy 61
Sung 201229 2.2 Glaucoma 98 Cirrus
SD-OCT
Optic disc photos,
red-free RNFL photos,
visual field
RNFL
macular
By photographs, glaucoma progressors had
structural rates of RNFL change of −1.19 μm/year
and macular thickness −4.74 μm/year. By visual
field index, glaucoma progressors had structural
rates of RNFL change of −2.08 μm/year and macular
thickness −5.12 μm/year. Only macular rates of
change were significantly different from glaucoma
non-progressors
Na 201330 2.2 Glaucoma 279 Cirrus
SD-OCT
Optic disc photos,
red-free RNFL photos,
visual field
RNFL
ONH
macular
Glaucoma progressors had significantly different
rates of structural change in RNFL (−1.26 μm/year),
rim area (−0.02 mm2/year), average cup to disc ratio
(0.004/year) and macular cube volume (−0.07 μm/
year) compared with glaucoma non-progressors
GCC, ganglion cell complex; GCIPL, ganglion cell inner plexiform layer; OCT, optical coherence tomography; ONH, optic nerve head; RNFL, retinal nerve fibre layer; SD-OCT, spectral
domain-optical coherence tomography; TD-OCT, time domain-optical coherence tomography; TMT, total macular thickness.
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SD-OCT has been reported to be more sensitive than
TD-OCT in detecting RNFL changes in glaucoma progres-
sion.24 SD-OCT glaucoma progression algorithms measure
changes based on either event-based or trend-based analysis.
Event-based analysis detects progression when a follow-up meas-
urement exceeds a pre-established threshold for change from
baseline. This analysis identifies a gradual change over time that
eventually crosses a threshold or an acute event that exceeds a
threshold. The limitation of this approach is the susceptibility to
the effect of outliers that can be inappropriately labelled as pro-
gression. Trend-based analysis detects progression by evaluating
the slope of measured parameter over time. Trend analysis is
less sensitive to measurement variability and identifies a rate of
progression that may be extrapolated for time-to-event predic-
tions. The limitation of this approach is the requirement for a
large number of tests before the analysis can be considered as
reliable. Furthermore, trend analysis has an a priori assumption
of a linear rate of structural loss, which might not be applicable
for all eyes.
Table 2 summarises selected longitudinal studies of glaucoma
progression. The first study to show the potential of OCT in
detecting glaucoma progression used an event-based approach to
evaluate TD-OCT RNFL thickness measurements over time and
reported a mean loss of average RNFL thickness of 11.7 μm over
4.7 years in glaucoma subjects.25 In a longitudinal SD-OCTstudy
of glaucoma and healthy eyes followed for 3 years, the investiga-
tors reported a significantly greater rate of RNFL loss in glau-
comatous optic disc progressors compared with
non-progressors.26 A 2-year study of perimetric glaucoma and
healthy eyes with SD-OCT scans demonstrated superior detec-
tion of early glaucomatous progression with measurement of
GCC global loss volume and focal loss volume compared with
ONH, RNFL thickness and average GCC parameters.27
A longitudinal study of glaucoma and healthy eyes reported
that compared with RNFL, TMT and GCIPL showed similar
levels of sensitivity in glaucoma progression detection.28 A lon-
gitudinal study of eyes with advanced glaucoma, as determined
by VF, demonstrated that the rate of average macular thickness
loss was significantly greater in the progressed group versus the
stable and undetermined groups.29 Furthermore, the rate of
average RNFL thickness loss was similar among the groups, sug-
gesting that macular thickness assessment may be used to detect
progression in advanced glaucoma. Another longitudinal study
of 279 glaucoma eyes reported that RNFL thickness, macular
and ONH parameters decreased significantly faster in progres-
sors versus non-progressors as determined by optic disc, RNFL
and VF assessment.30 These studies indicate that the macular
region is appropriate for detection of glaucoma progression;
however, they are all limited by short follow-up periods that did
not last more than 2 years.
Myopia confounds the evaluation of glaucoma progression
because it is difficult to discern the difference between progres-
sion due primarily to myopia or glaucoma. Since it is not pos-
sible to distinguish glaucomatous from non-glaucomatous
changes based on a single examination, it is appropriate to con-
servatively follow highly myopic patients with suspected glau-
coma after establishing baseline structural and functional
parameters.15 As of this manuscript, no study has attempted to
evaluate the effect of myopia on detection of glaucoma
progression.
In summary, the literature to date suggests that RNFL thickness
is a dominant parameter in detection of glaucoma progression.
However, macular parameters might provide a useful alternative
for glaucoma progression assessment. The results of all available
studies need to be cautiously evaluated in light of the relatively
short duration of follow-up in the context of the typically slowly
progressing glaucoma.
CONCLUSIONS
SD-OCT is a valuable clinical tool for glaucoma diagnosis and
detection of progression. RNFL parameters have been demon-
strated to provide accurate information for disease diagnosis and
sensitive method for disease progression. Initial studies evaluat-
ing macular and ONH parameters show encouraging results.
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